NASDAQ: RLMD Investor Notice: Investigation over Possible Wrongdoing at Relmada Therapeutics, Inc.
An investigation on behalf of investors in Relmada Therapeutics, Inc. (NASDAQ: RLMD) shares over potential wrongdoing at Relmada Therapeutics, Inc. was announced and NASDAQ: RLMD stockholders should contact the Shareholders Foundation.
View full press release